SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

Baker, EH; Patel, K; Ball, J; Edwards, S; Harrison, TS; Kaul, A; Koh, M; Krishna, S; Leaver, S; Kumar, V; et al. Baker, EH; Patel, K; Ball, J; Edwards, S; Harrison, TS; Kaul, A; Koh, M; Krishna, S; Leaver, S; Kumar, V; Forton, DM (2021) Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials. Br J Clin Pharmacol, 87 (3). pp. 1584-1586. ISSN 1365-2125 https://doi.org/10.1111/bcp.14466
SGUL Authors: Baker, Emma Harriet Harrison, Thomas Stephen Krishna, Sanjeev

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (50kB)
[img] Microsoft PowerPoint (Figure 1) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (1MB)
Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Baker, E.H., Patel, K., Ball, J., Edwards, S., Harrison, T.S., Kaul, A., Koh, M., Krishna, S., Leaver, S., Kumar, V. and Forton, D.M. (2021), Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials. Br J Clin Pharmacol, 87: 1584-1586, which has been published in final form at https://doi.org/10.1111/bcp.14466. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: Pharmacology & Pharmacy, 1115 Pharmacology and Pharmaceutical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Br J Clin Pharmacol
ISSN: 1365-2125
Language: eng
Dates:
DateEvent
2 March 2021Published
14 July 2020Published Online
15 June 2020Accepted
Publisher License: Publisher's own licence
PubMed ID: 32656822
Web of Science ID: WOS:000555038800001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112177
Publisher's version: https://doi.org/10.1111/bcp.14466

Actions (login required)

Edit Item Edit Item